Among numerous studies on metformin's antiplastic mechanisms, EMT inhibition was first reported in MDA-MB-231 and transforming growth factor beta- (TGF-β-) induced MCF-7 breast cancer cells [17, 18]. This evidence concerns the gene TGFB1 and breast carcinoma.